MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Context Therapeutics (CNTX) Ownership - Who owns Context Therapeutics?

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

Profile

Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
144.25M
P/E Ratio
N/A
Total Cash
76.94M
Projected Growth
N/A
Total Debt
140.2K
Revenue
N/A
Risk (Beta)
2.37
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CNTX
Capitalization
144M
P/E Ratio
N/A
Risk (Beta)
2.37
Dividend Yield
N/A
Total Cash
76.9M
Total Cash/Share
0.84
Total Debt
140K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
73.2M
P/B Ratio
1.97
Cash Flow
N/A
Earnings
-0.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
91.9K
Current Ratio
13.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-30.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.94
Shares Held By Institutions
73.5M
Shares Outstanding - Current
91.9M
Total Liabilities
6.06M
Total Volume MTD
N/A
Value
1
Gain YTD
6.803
View a ticker or compare two or three
CNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CNTX showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com